QILU FDA Approval ANDA 204368

ANDA 204368

QILU

FDA Drug Application

Application #204368

Application Sponsors

ANDA 204368QILU

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001INJECTABLE;INTRAVENOUS50MG/10ML (5MG/ML)0OXALIPLATINOXALIPLATIN
002INJECTABLE;INTRAVENOUS100MG/20ML (5MG/ML)0OXALIPLATINOXALIPLATIN
003INJECTABLE;INTRAVENOUS200MG/40ML (5MG/ML)0OXALIPLATINOXALIPLATIN

FDA Submissions

UNKNOWN; ORIG1AP2016-06-07
LABELING; LabelingSUPPL3AP2021-11-17STANDARD
LABELING; LabelingSUPPL5AP2021-11-17STANDARD

Submissions Property Types

ORIG1Null15
SUPPL3Null7
SUPPL5Null7

TE Codes

001PrescriptionAP
002PrescriptionAP
003PrescriptionAP

CDER Filings

QILU
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204368
            [companyName] => QILU
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"50MG\/10ML (5MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"100MG\/20ML (5MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"200MG\/40ML (5MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/07\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-06-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.